Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer - PubMed (original) (raw)
Nimbolide epigenetically regulates autophagy and apoptosis in breast cancer
Venkatesh Pooladanda et al. Toxicol In Vitro. 2018 Sep.
Abstract
Autophagy is a critical regulator of cellular homeostasis and its dysregulation often results in various disease manifestations, including cancer. Nimbolide, an active chemical constituent of neem (Azadirachta indica) exhibits potent anticancer effects. Although, nimbolide mediated apoptosis activation in breast cancer cells is well known. Nevertheless, its role in autophagy induction mechanism and epigenetic alteration is not explored previously. Our current study intended to bridge the gaps in the existing research by exploring the potential of nimbolide in inducing autophagy, which could counter regulate the transformations in breast cancer. In our studies, nimbolide significantly inhibited the cell proliferation of MDA-MB-231 and MCF-7 cells with IC50 values of 1.97 ± 0.24 and 5.04 ± 0.25 μM, respectively. Nimbolide markedly arrested the cell cycle progression and cell survival with loss of mitochondrial membrane potential by reducing Bcl-2 concomitantly inducing Bax and caspases protein expression with modulation of HDAC-2 and H3K27Ac expression. Consequently, characteristic autophagolysosome accumulation was observed by acridine orange, monodansylcadaverine (MDC) and Lysotracker Red staining. Moreover, nimbolide induced autophagy signaling by increasing Beclin 1 and LC3B along with decreased p62 and mTOR protein expression. Thus, our findings imply that nimbolide induces autophagy mediated apoptotic cell death in breast cancer with epigenetic modifications.
Keywords: Apoptosis; Autophagy; H3K27Ac; HDAC-2; Nimbolide.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
- Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway.
Elumalai P, Gunadharini DN, Senthilkumar K, Banudevi S, Arunkumar R, Benson CS, Sharmila G, Arunakaran J. Elumalai P, et al. Toxicol Lett. 2012 Nov 30;215(2):131-42. doi: 10.1016/j.toxlet.2012.10.008. Epub 2012 Oct 23. Toxicol Lett. 2012. PMID: 23089555 - Nimbolide, a neem limonoid inhibits cytoprotective autophagy to activate apoptosis via modulation of the PI3K/Akt/GSK-3β signalling pathway in oral cancer.
Sophia J, Kowshik J, Dwivedi A, Bhutia SK, Manavathi B, Mishra R, Nagini S. Sophia J, et al. Cell Death Dis. 2018 Oct 23;9(11):1087. doi: 10.1038/s41419-018-1126-4. Cell Death Dis. 2018. PMID: 30352996 Free PMC article. - Methyl 3-hydroxyimino-11-oxoolean-12-en-28-oate (HIMOXOL), a synthetic oleanolic acid derivative, induces both apoptosis and autophagy in MDA-MB-231 breast cancer cells.
Lisiak N, Paszel-Jaworska A, Bednarczyk-Cwynar B, Zaprutko L, Kaczmarek M, Rybczyńska M. Lisiak N, et al. Chem Biol Interact. 2014 Feb 5;208:47-57. doi: 10.1016/j.cbi.2013.11.009. Epub 2013 Nov 27. Chem Biol Interact. 2014. PMID: 24291674 - Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal.
Nagini S, Nivetha R, Palrasu M, Mishra R. Nagini S, et al. J Med Chem. 2021 Apr 8;64(7):3560-3577. doi: 10.1021/acs.jmedchem.0c02239. Epub 2021 Mar 19. J Med Chem. 2021. PMID: 33739088 Review. - Insights into Nimbolide molecular crosstalk and its anticancer properties.
Shaheen S, Khalid S, Aaliya K, Gul A, Hafeez A, Armaghan M, Almarhoon ZM, Calina D, Khan K, Sharifi-Rad J. Shaheen S, et al. Med Oncol. 2024 May 18;41(6):158. doi: 10.1007/s12032-024-02379-5. Med Oncol. 2024. PMID: 38761317 Review.
Cited by
- Nimbolide: promising agent for prevention and treatment of chronic diseases (recent update).
Rajendran P, Renu K, Abdallah BM, Ali EM, Veeraraghavan VP, Sivalingam K, Rustagi Y, Abdelsalam SA, Ibrahim RIH, Al-Ramadan SY. Rajendran P, et al. Food Nutr Res. 2024 Mar 18;68. doi: 10.29219/fnr.v68.9650. eCollection 2024. Food Nutr Res. 2024. PMID: 38571915 Free PMC article. - Unveiling the pharmacological potential of plant triterpenoids in breast cancer management: an updated review.
Aly SH, Elbadry AMM, Doghish AS, El-Nashar HAS. Aly SH, et al. Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5571-5596. doi: 10.1007/s00210-024-03054-2. Epub 2024 Apr 2. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38563878 Free PMC article. Review. - Autophagy Regulators in Cancer.
Zhang J, Xiang Q, Wu M, Lao YZ, Xian YF, Xu HX, Lin ZX. Zhang J, et al. Int J Mol Sci. 2023 Jun 30;24(13):10944. doi: 10.3390/ijms241310944. Int J Mol Sci. 2023. PMID: 37446120 Free PMC article. Review. - Epigenetic effects of herbal medicine.
Wu YY, Xu YM, Lau ATY. Wu YY, et al. Clin Epigenetics. 2023 May 13;15(1):85. doi: 10.1186/s13148-023-01481-1. Clin Epigenetics. 2023. PMID: 37179342 Free PMC article. Review. - Exploring the anti-cancer potential of dietary phytochemicals for the patients with breast cancer: A comprehensive review.
Sohel M, Aktar S, Biswas P, Amin MA, Hossain MA, Ahmed N, Mim MIH, Islam F, Mamun AA. Sohel M, et al. Cancer Med. 2023 Jul;12(13):14556-14583. doi: 10.1002/cam4.5984. Epub 2023 May 3. Cancer Med. 2023. PMID: 37132286 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous